Harmony Biosciences announced that Glenn Reicin is stepping down as Chief Financial Officer effective July 16, 2026, and that Stephen Mollichella has been appointed Interim Principal Financial Officer effective the same date.
| IndividualGlenn ReicinStephen Mollichella | RoleChief Financial OfficerSenior Vice President and Controller; Interim Principal Financial Officer | Type of ChangeStepping downAppointed (Interim) | Effective DateJuly 16, 2026July 16, 2026 | ReasonTo pursue other career opportunitiesNot disclosed | Replacement InfoInterim Principal Financial Officer appointed: Stephen MollichellaN/A | Background DetailsNot disclosedMore than two decades of finance and accounting leadership; joined Harmony Biosciences in 2021; led accounting, reporting, team building, systems, governance, and supported business development (per filing) | Board/Committee Role ChangesNot disclosedNot disclosed |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.